China Medicine Stock Buy Hold or Sell Recommendation

CHME Stock  USD 0.0001  0.00  0.00%   
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding China Medicine is 'Not Rated'. Macroaxis provides China Medicine buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CHME positions. The advice algorithm takes into account all of China Medicine's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting China Medicine's buy or sell advice are summarized below:
Real Value
0.0
Hype Value
0.0
Market Value
0.0001
Naive Value
0.0001
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell China Medicine given historical horizon and risk tolerance towards China Medicine. When Macroaxis issues a 'buy' or 'sell' recommendation for China Medicine, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out China Medicine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as China and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards China Medicine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Execute China Medicine Buy or Sell Advice

The China recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on China Medicine. Macroaxis does not own or have any residual interests in China Medicine or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute China Medicine's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell China MedicineBuy China Medicine
Not Rated
For the selected time horizon China Medicine has a Return On Equity of 0.0663, Return On Asset of 0.0782, Profit Margin of 0.09 %, Operating Margin of 0.18 %, Current Valuation of 2 M and Shares Outstanding of 23.71 M
We provide trade advice to complement the prevailing expert consensus on China Medicine. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure China Medicine is not overpriced, please confirm all China Medicine fundamentals, including its price to earning, net income, book value per share, as well as the relationship between the revenue and total debt . As China Medicine appears to be a penny stock we also recommend to validate its price to book numbers.

China Medicine Trading Alerts and Improvement Suggestions

China Medicine generated a negative expected return over the last 90 days
China Medicine has some characteristics of a very speculative penny stock
China Medicine has high likelihood to experience some financial distress in the next 2 years

China Medicine Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to China Medicine or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that China Medicine's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a China pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.00
β
Beta against NYSE Composite0.00
σ
Overall volatility
0.00
Ir
Information ratio 0.00

China Medicine Volatility Alert

At this time China Medicine exhibits very low volatility. China Medicine appears to be a penny stock. Although China Medicine may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in China Medicine or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on China instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

China Medicine Fundamentals Vs Peers

Comparing China Medicine's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze China Medicine's direct or indirect competition across all of the common fundamentals between China Medicine and the related equities. This way, we can detect undervalued stocks with similar characteristics as China Medicine or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of China Medicine's fundamental indicators could also be used in its relative valuation, which is a method of valuing China Medicine by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare China Medicine to competition
FundamentalsChina MedicinePeer Average
Return On Equity0.0663-0.31
Return On Asset0.0782-0.14
Profit Margin0.09 %(1.27) %
Operating Margin0.18 %(5.51) %
Current Valuation2 M16.62 B
Shares Outstanding23.71 M571.82 M
Price To Earning(6.67) X28.72 X
Price To Book0.07 X9.51 X
Price To Sales0.01 X11.42 X
Revenue64.75 M9.43 B
Gross Profit18.98 M27.38 B
EBITDA13.41 M3.9 B
Net Income1.72 M570.98 M
Cash And Equivalents7.85 M2.7 B
Cash Per Share0.20 X5.01 X
Total Debt4.05 M5.32 B
Debt To Equity0.03 %48.70 %
Current Ratio11.15 X2.16 X
Book Value Per Share1.97 X1.93 K
Cash Flow From Operations16.96 M971.22 M
Earnings Per Share(0.01) X3.12 X
Number Of Employees28118.84 K
Beta36.82-0.15
Market Capitalization284.54 K19.03 B
Total Asset66.84 M29.47 B
Retained Earnings24.76 M9.33 B
Working Capital85.75 M1.48 B
Current Asset94.2 M9.34 B
Current Liabilities8.45 M7.9 B
Z Score1.28.72
Net Asset66.84 M

China Medicine Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as China . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About China Medicine Buy or Sell Advice

When is the right time to buy or sell China Medicine? Buying financial instruments such as China Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having China Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Providers Thematic Idea Now

Insurance Providers
Insurance Providers Theme
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
View All  Next Launch
Check out China Medicine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for China Pink Sheet analysis

When running China Medicine's price analysis, check to measure China Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medicine is operating at the current time. Most of China Medicine's value examination focuses on studying past and present price action to predict the probability of China Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medicine's price. Additionally, you may evaluate how the addition of China Medicine to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Please note, there is a significant difference between China Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.